Jubilant Ingrevia has raised Rs 100 crore through Commercial Papers (CPs). The maturity of the said Commercial Papers will be on December 11, 2024. Tenure of the instrument is 90 days.
The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 300 crore.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.